Interleukin-1 beta and tumor necrosis factor alpha inhibit migration activity of chondrogenic progenitor cells from non-fibrillated osteoarthritic cartilage

Arthritis Research and Therapy

Volumn 15, Issue 5, 2013, Pages

  Joos, Helga ^a   Wildner, Anja ^a   Hogrefe, Cathrin ^a   Reichel, Heiko ^a   Brenner, Rolf E ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

cartilage repair; Chondrogenic progenitor cells (CPC); IL 1 ; migration; TNF

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; LEUKOCYTE ANTIGEN; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB;

ADIPOGENESIS; ADOLESCENT; ADULT; ARTICLE; BASAL CELL; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL MIGRATION; CHONDROGENESIS; CHONDROGENIC PROGENITOR CELL; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STROMA CELL; MIGRATION INHIBITION; OSTEOARTHRITIS; STEM CELL; AGED; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL CULTURE; CELL MOTION; CHEMISTRY; CULTURE MEDIUM; DOSE RESPONSE; DRUG EFFECT; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; TISSUE CULTURE TECHNIQUE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CHONDROCYTES; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-1BETA; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; OSTEOARTHRITIS; PROTO-ONCOGENE PROTEINS C-SIS; STEM CELLS; TISSUE CULTURE TECHNIQUES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84883683952     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4299     Document Type: Article

References (55)

1. Anderson DD, Chubinskaya S, Guilak F, Martin JA, Oegema TR, Olson SA, Buckwalter JA. Post-traumatic osteoarthritis: improved understanding and opportunities for early intervention. J Orthop Res 2011, 29:802-809. 10.1002/jor.21359, 3082940, 21520254.
2. Steadman JR, Rodkey WG, Rodrigo JJ. Microfracture: surgical technique and rehabilitation to treat chondral defects. Clin Orthop Relat Res 2001, (:):S362-369.
3. Pridie KH. The development and nature of osteoarthritis of the hip joint. Rheumatism 1955, 11:2-7.
4. Pascarella A, Ciatti R, Pascarella F, Latte C, Di Salvatore MG, Liguori L, Iannella G. Treatment of articular cartilage lesions of the knee joint using a modified AMIC technique. Knee Surg Sports Traumatol Arthrosc 2010, 18:509-513. 10.1007/s00167-009-1007-6, 20012016.
5. Fiedler J, Brill C, Blum WF, Brenner RE. IGF-I and IGF-II stimulate directed cell migration of bone-marrow-derived human mesenchymal progenitor cells. Biochem Biophys Res Commun 2006, 345:1177-1183. 10.1016/j.bbrc.2006.05.034, 16716263.
6. Fiedler J, Etzel N, Brenner RE. To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem 2004, 93:990-998. 10.1002/jcb.20219, 15389881.
7. Fiedler J, Roderer G, Gunther KP, Brenner RE. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 2002, 87:305-312. 10.1002/jcb.10309, 12397612.
8. Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, Charbord P, Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25:1737-1745. 10.1634/stemcells.2007-0054, 17395768.
9. Schmidt A, Ladage D, Schinkothe T, Klausmann U, Ulrichs C, Klinz FJ, Brixius K, Arnhold S, Desai B, Mehlhorn U, Schwinger RH, Staib P, Addicks K, Bloch W. Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells 2006, 24:1750-1758. 10.1634/stemcells.2005-0191, 16822883.
10. Orth P, Goebel L, Wolfram U, Ong MF, Graber S, Kohn D, Cucchiarini M, Ignatius A, Pape D, Madry H. Effect of subchondral drilling on the microarchitecture of subchondral bone: analysis in a large animal model at 6 months. Am J Sports Med 2012, 40:828-836. 10.1177/0363546511430376, 22223716.
11. Noth U, Osyczka AM, Tuli R, Hickok NJ, Danielson KG, Tuan RS. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 2002, 20:1060-1069. 10.1016/S0736-0266(02)00018-9, 12382974.
12. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001, 44:1928-1942. 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P, 11508446.
13. Jones EA, Crawford A, English A, Henshaw K, Mundy J, Corscadden D, Chapman T, Emery P, Hatton P, McGonagle D. Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. Arthritis Rheum 2008, 58:1731-1740. 10.1002/art.23485, 18512779.
14. Sekiya I, Ojima M, Suzuki S, Yamaga M, Horie M, Koga H, Tsuji K, Miyaguchi K, Ogishima S, Tanaka H, Muneta T. Human mesenchymal stem cells in synovial fluid increase in the knee with degenerated cartilage and osteoarthritis. J Orthop Res 2012, 30:943-949. 10.1002/jor.22029, 22147634.
15. Wickham MQ, Erickson GR, Gimble JM, Vail TP, Guilak F. Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop Relat Res 2003, (:):196-212.
16. Alsalameh S, Amin R, Gemba T, Lotz M. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum 2004, 50:1522-1532. 10.1002/art.20269, 15146422.
17. Fickert S, Fiedler J, Brenner RE. Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers. Arthritis Res Ther 2004, 6:R422-432. 10.1186/ar1210, 546281, 15380042.
18. Hiraoka K, Grogan S, Olee T, Lotz M. Mesenchymal progenitor cells in adult human articular cartilage. Biorheology 2006, 43:447-454.
19. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317. 10.1080/14653240600855905, 16923606.
20. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, Markham AF, Jack A, Emery P, McGonagle D. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002, 46:3349-3360. 10.1002/art.10696, 12483742.
21. Sobiesiak M, Sivasubramaniyan K, Hermann C, Tan C, Orgel M, Treml S, Cerabona F, de Zwart P, Ochs U, Muller CA, Gargett CE, Kalbacher H, Buhring HJ. The mesenchymal stem cell antigen MSCA-1 is identical to tissue non-specific alkaline phosphatase. Stem Cells Dev 2010, 19:669-677. 10.1089/scd.2009.0290, 19860546.
22. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147. 10.1126/science.284.5411.143, 10102814.
23. Williams R, Khan IM, Richardson K, Nelson L, McCarthy HE, Analbelsi T, Singhrao SK, Dowthwaite GP, Jones RE, Baird DM, Lewis H, Roberts S, Shaw HM, Dudhia J, Fairclough J, Briggs T, Archer CW. Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage. PLoS One 2010, 5:e13246. 10.1371/journal.pone.0013246, 2954799, 20976230.
24. Dowthwaite GP, Bishop JC, Redman SN, Khan IM, Rooney P, Evans DJ, Haughton L, Bayram Z, Boyer S, Thomson B, Wolfe MS, Archer CW. The surface of articular cartilage contains a progenitor cell population. J Cell Sci 2004, 117:889-897. 10.1242/jcs.00912, 14762107.
25. Koelling S, Kruegel J, Irmer M, Path JR, Sadowski B, Miro X, Miosge N. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Cell Stem Cell 2009, 4:324-335. 10.1016/j.stem.2009.01.015, 19341622.
26. Seol D, McCabe DJ, Choe H, Zheng H, Yu Y, Jang K, Walter MW, Lehman AD, Ding L, Buckwalter JA, Martin JA. Chondrogenic progenitor cells respond to cartilage injury. Arthritis Rheum 2012, 64:3626-3637. 10.1002/art.34613, 22777600.
27. Gerter R, Kruegel J, Miosge N. New insights into cartilage repair - the role of migratory progenitor cells in osteoarthritis. Matrix Biol 2012, 31:206-213. 10.1016/j.matbio.2012.01.007, 22266025.
28. Buhrmann C, Mobasheri A, Matis U, Shakibaei M. Curcumin mediated suppression of nuclear factor-kappaB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment. Arthritis Res Ther 2010, 12:R127. 10.1186/ar3065, 2945017, 20594343.
29. Kouri JB, Jiménez SA, Quintero M, Chico A. Ultrastructural study of chondrocytes from fibrillated and non-fibrillated human osteoarthritic cartilage. Osteoarthritis Cartilage 1996, 4:111-125. 10.1016/S1063-4584(05)80320-6, 8806113.
30. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 2007, 9:204. 10.1186/ar2116, 1860068, 17316462.
31. Joos H, Hogrefe C, Rieger L, Durselen L, Ignatius A, Brenner RE. Single impact trauma in human early-stage osteoarthritic cartilage: Implication of prostaglandin D2 but no additive effect of IL-1beta on cell survival. Int J Mol Med 2011, 28:271-277.
32. Zigmond S. Leucocyte locomotion and chemotaxis. Nouv Rev Fr Hematol 1973, 13:886-887.
33. Barbero A, Ploegert S, Heberer M, Martin I. Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum 2003, 48:1315-1325. 10.1002/art.10950, 12746904.
34. de la Fuente R, Abad JL, Garcia-Castro J, Fernandez-Miguel G, Petriz J, Rubio D, Vicario-Abejon C, Guillen P, Gonzalez MA, Bernad A. Dedifferentiated adult articular chondrocytes: a population of human multipotent primitive cells. Exp Cell Res 2004, 297:313-328. 10.1016/j.yexcr.2004.02.026, 15212937.
35. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C, Teng PN, Traas J, Schugar R, Deasy BM, Badylak S, Buhring HJ, Giacobino JP, Lazzari L, Huard J, Peault B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3:301-313. 10.1016/j.stem.2008.07.003, 18786417.
36. Halfon S, Abramov N, Grinblat B, Ginis I. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev 2011, 20:53-66. 10.1089/scd.2010.0040, 20528146.
37. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336. 10.1016/j.cell.2007.08.025, 17956733.
38. Pullig O, Weseloh G, Ronneberger D, Käkönen S, Swoboda B. Chondrocyte differentiation in human osteoarthritis: expression of osteocalcin in normal and osteoarthritic cartilage and bone. Calcif Tissue Int 2000, 67:230--240. 10.1007/s002230001108, 10954778.
39. Pelttari K, Winter A, Steck E, Goetzke K, Hennig T, Ochs BG, Aigner T, Richter W. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 2006, 54:3254-3266. 10.1002/art.22136, 17009260.
40. Schmidt MB, Chen EH, Lynch SE. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage 2006, 14:403-412. 10.1016/j.joca.2005.10.011, 16413799.
41. Montaseri A, Busch F, Mobasheri A, Buhrmann C, Aldinger C, Rad JS, Shakibaei M. IGF-1 and PDGF-bb suppress IL-1beta-induced cartilage degradation through down-regulation of NF-kappaB signaling: involvement of Src/PI-3K/AKT pathway. PLoS One 2011, 6:e28663. 10.1371/journal.pone.0028663, 3237481, 22194879.
42. Madry H, Kaul G, Cucchiarini M, Stein U, Zurakowski D, Remberger K, Menger MD, Kohn D, Trippel SB. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther 2005, 12:1171-1179. 10.1038/sj.gt.3302515, 15815701.
43. Stevens AL, Wishnok JS, Chai DH, Grodzinsky AJ, Tannenbaum SR. A sodium dodecyl sulfate-polyacrylamide gel electrophoresis-liquid chromatography tandem mass spectrometry analysis of bovine cartilage tissue response to mechanical compression injury and the inflammatory cytokines tumor necrosis factor alpha and interleukin-1beta. Arthritis Rheum 2008, 58:489-500. 10.1002/art.23120, 18240213.
44. Stevens AL, Wishnok JS, White FM, Grodzinsky AJ, Tannenbaum SR. Mechanical injury and cytokines cause loss of cartilage integrity and upregulate proteins associated with catabolism, immunity, inflammation, and repair. Mol Cell Proteomics 2009, 8:1475-1489. 10.1074/mcp.M800181-MCP200, 2709180, 19196708.
45. Thibault MM, Hoemann CD, Buschmann MD. Fibronectin, vitronectin, and collagen I induce chemotaxis and haptotaxis of human and rabbit mesenchymal stem cells in a standardized transmembrane assay. Stem Cells Dev 2007, 16:489-502. 10.1089/scd.2006.0100, 17610379.
46. Song JJ, Aswad R, Kanaan RA, Rico MC, Owen TA, Barbe MF, Safadi FF, Popoff SN. Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF-beta1 to induce mesenchymal cell condensation. J Cell Physiol 2007, 210:398-410. 10.1002/jcp.20850, 17111364.
47. Zou C, Song G, Luo Q, Yuan L, Yang L. Mesenchymal stem cells require integrin beta1 for directed migration induced by osteopontin in vitro. In Vitro Cell Dev Biol Anim 2011, 47:241-250. 10.1007/s11626-010-9377-0, 21136191.
48. Milentijevic D, Rubel IF, Liew AS, Helfet DL, Torzilli PA. An in vivo rabbit model for cartilage trauma: a preliminary study of the influence of impact stress magnitude on chondrocyte death and matrix damage. J Orthop Trauma 2005, 19:466-473. 10.1097/01.bot.0000162768.83772.18, 16056079.
49. Irie K, Uchiyama E, Iwaso H. Intraarticular inflammatory cytokines in acute anterior cruciate ligament injured knee. Knee 2003, 10:93-96. 10.1016/S0968-0160(02)00083-2, 12649034.
50. Joos H, Albrecht W, Laufer S, Reichel H, Brenner RE. IL-1beta regulates FHL2 and other cytoskeleton-related genes in human chondrocytes. Mol Med 2008, 14:150-159. 2213891, 18224250.
51. Spaeth EL, Marini FC. Dissecting mesenchymal stem cell movement: migration assays for tracing and deducing cell migration. Methods Mol Biol 2011, 750:241-259. 10.1007/978-1-61779-145-1_17, 21618096.
52. Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol 2011, 23:471-478. 10.1097/BOR.0b013e328349c2b1, 21788902.
53. Lu Y, Dhanaraj S, Wang Z, Bradley DM, Bowman SM, Cole BJ, Binette F. Minced cartilage without cell culture serves as an effective intraoperative cell source for cartilage repair. J Orthop Res 2006, 24:1261-1270. 10.1002/jor.20135, 16652342.
54. Wehling N, Palmer GD, Pilapil C, Liu F, Wells JW, Muller PE, Evans CH, Porter RM. Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways. Arthritis Rheum 2009, 60:801-812. 10.1002/art.24352, 2688727, 19248089.
55. Koelling S, Miosge N. Sex differences of chondrogenic progenitor cells in late stages of osteoarthritis. Arthritis Rheum 2010, 62:1077-1087. 10.1002/art.27311, 20131243.